Loading the section…
The price of Phibro Animal Health Corporation (PAHC) on October 9, 2026 is 38.30 USD, +2.41% on the day. Over 52 weeks the stock traded between 28.25 USD and 60.08 USD; the price now sits 32% of the way up that range. Over the past year the price changed by +3.21%. The P/E ratio is 16.5, which is below the sector median (25.0). Market capitalization is 1.57 billion USD, rank 91 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 4 November 2026 · Earnings calendar
Change over the period shown (line colour): +4.70 %
Phibro Animal Health Corporation trades on Nasdaq under the ticker PAHC. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PAHC has traded between 28.25 $ and 60.08 $. As of 9 October 2026 the price stood 31.57 % of the way from the 52-week low to the high.
Over one year PAHC shares rose 3.21 %; over six months they fell 33.84 %. Volatility over 90 days is 37.59 %. Dividends are not included: this is price change only, as of 9 October 2026.
PAHC trades at a price-to-earnings ratio of 16.5, below the sector median of 25.0. Price to sales is 1.0, below the sector median of 4.0. Price to book is 4.3, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 37.40 | 39.26 | 37.40 | 38.30 | 235,900 |
| 8 October 2026 | 37.53 | 37.58 | 36.72 | 37.40 | 238,700 |
| 7 October 2026 | 36.43 | 37.93 | 36.03 | 37.72 | 199,500 |
| 6 October 2026 | 37.46 | 37.70 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
No events for this security recently.
Address:GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666, US
Phibro Animal Health Corporation reported revenue of 1.5B $ and net income of 95M $ over the last four quarters. Net margin is 6.35 %. Revenue changed by +25.98 % year over year. Earnings per share are 2.33 $. Market capitalisation is 1.6B $.
PAHC has a return on equity of 26.32 %, above the sector median of −41.68 %. Return on assets is 6.59 %, above the sector median of −32.11 %. Operating margin is 12.00 %, above the sector median of −26.84 %.
Phibro Animal Health Corporation pays dividends quarterly: 0.48 $ per share over the past twelve months, a yield of 1.25 %. The latest payment was 0.12 $, with an ex-dividend date of 2 September 2026.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 36.31 |
| 36.61 |
| 133,200 |
| 5 October 2026 | 37.14 | 38.05 | 37.05 | 37.19 | 280,000 |
| 2 October 2026 | 36.19 | 37.62 | 36.19 | 37.24 | 222,700 |
| 1 October 2026 | 35.58 | 36.23 | 35.18 | 35.87 | 275,000 |
| 30 September 2026 | 35.68 | 36.02 | 35.06 | 35.74 | 205,500 |
| 29 September 2026 | 35.46 | 35.72 | 34.70 | 35.45 | 170,500 |
| 28 September 2026 | 34.25 | 36.13 | 33.84 | 35.70 | 485,900 |
| 25 September 2026 | 33.93 | 34.66 | 33.52 | 34.45 | 206,600 |
| 24 September 2026 | 34.10 | 34.25 | 33.05 | 33.93 | 130,600 |
| 23 September 2026 | 35.14 | 36.04 | 34.04 | 34.10 | 141,500 |
| 22 September 2026 | 35.10 | 35.54 | 34.91 | 35.15 | 204,000 |
| 21 September 2026 | 34.71 | 35.39 | 34.46 | 34.68 | 141,300 |
| 18 September 2026 | 34.12 | 35.11 | 34.12 | 34.56 | 635,500 |
| 17 September 2026 | 35.64 | 35.64 | 34.40 | 34.45 | 212,000 |
| 16 September 2026 | 35.03 | 35.98 | 34.68 | 35.30 | 269,500 |
| 15 September 2026 | 36.00 | 36.00 | 34.94 | 35.03 | 322,800 |
| 14 September 2026 | 35.92 | 36.70 | 35.84 | 35.94 | 258,400 |